|
Volumn 3, Issue , 2004, Pages
|
Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmenigeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFEPIME;
CEFOTAXIME;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BACTERIUM ISOLATE;
BACTERIUM ISOLATION;
CONTROLLED STUDY;
DATA BASE;
INFECTION CONTROL;
LABORATORY TEST;
MENINX;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
QUALITATIVE ANALYSIS;
QUANTITATIVE ANALYSIS;
STANDARDIZATION;
STREPTOCOCCUS PNEUMONIAE;
UNITED STATES;
|
EID: 3042651159
PISSN: 14760711
EISSN: None
Source Type: Journal
DOI: 10.1186/1476-0711-3-1 Document Type: Article |
Times cited : (4)
|
References (5)
|